ICC: Cefixime Safe For Children With Relapsing Urinary Tract Infection
Unregistered User
If this is not your name, click here.
Contact Us | Order Now | Journals | Bookstore | Register a colleague
 
  SEARCH  
News
Bookstore
Medline
The Web
Meetings & Congresses
Complete Doctor's Guide
 


 EXPLORE :
 news  All News
 webcasts All Webcasts
 All cases All Cases
 Meetings All Meetings & Congresses
 Medical All Medical Resources

top





New drugs / indications

English Dictionary

Medical Dictionary

Thesaurus



Warning | Privacy | Awards



 Favourite Journals 

Click here to choose your favourite journals


 Favourite Sites 

Click here to choose your favourite sites


 Languages 



  




ICC: Cefixime Safe For Children With Relapsing Urinary Tract Infection

By Pamela A Hunter
Special to DG News

AMSTERDAM, THE NETHERLANDS -- July 3, 2001 -- Young children with relapsing urinary tract infections (UTIs) are vulnerable to kidney damage and kidney function needs to be monitored carefully if any antibiotic treatment is given.

Dr V. Fanos and colleagues (University of Verona and Laboratory Department, Padua, Italy) presented data at the 22nd International Congress of Chemotherapy, Amsterdam, July 1st-3rd, 2001 showing that the broad spectrum cephalosporin cefixime is safe to administer prophylactically to young children with recurrent UTI.

They studied 10 males and 10 females aged between one month and four years all of whom had a history of at least two episodes of UTI in the previous two months. The predominant organisms (78.2 percent) causing the infections were Escherichia coli and Proteus mirabilis.

The authors used two assays to monitor kidney function; detection of urinary levels of N-acetyl-beta-D-glucosaminidase (NAG), using a colorimetric method and urinary levels of creatinine, using the Jaffe kinetic method. These methods provide a sensitive measure of any potential damage to the kidney. Blood urea nitrogen (BUN) determinations and other kidney function tests were also made at intervals. Urine samples were collected at weekly intervals for NAG and creatinine measurements.

The children received a 4 mg/kg dose of cefixime at bedtime for a period of one to two months. The urinary NAG levels were 0.508 (+/- 0.307) with a range of 0.05-1.17. These values were well within the quoted normal range for paediatric patients (upper limit of normal range 1 U/mmol) with only one patient having a value (1.17) just outside the normal range. All other kidney function tests were normal, including BUN and serum and urinary creatinine. No infections occurred during the period of treatment.

Cefixime proved to be well tolerated and effective as a prophylactic agent in these very young children with recurrent UTI.

E-mail this page
to a friend or colleague!
To print,
use this version




Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer.

If you have any technical questions or other concerns about this site, feel free to contact us at webmaster@docguide.com.

All contents Copyright (c) 1995- Doctor's Guide Publishing Limited. All rights reserved.


Employment opportunities | Partnering opportunities